Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic charcter.
D000367:Age Factors; D000477:Alkylating Agents / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D009369:Neoplasms / Q000473:pathology; D009447:Neuroblastoma / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000266:history / Q000276:immunology / Q000378:metabolism / Q000401:mortality / Q000503:physiopathology* / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D012737:Sex Factors; D013997:Time Factors; D014748:Vinca Alkaloids / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D014748:Vinca Alkaloids; D014750:Vincristine; D003520:Cyclophosphamide